PF-Atlas › Mechanisms › PDE4B Inhibition

PDE4B Inhibition in IPF

Mechanism of action · idiopathic pulmonary fibrosis

Overview

PDE4B Inhibition is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 2 clinical trials acting through this mechanism.

Drugs targeting PDE4B Inhibition

Nerandomilast

Clinical trials

Nerandomilast — FIBRONEER-IPF Nerandomilast — FIBRONEER-ILD

Medical disclaimer. This is a research summary, not medical advice.